We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+7.86%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
AUM
$234M
AUM Growth
-$5.63M
Cap. Flow
-$22.7M
Cap. Flow %
-9.71%
Top 10 Hldgs %
77.03%
Holding
114
New
24
Increased
15
Reduced
9
Closed
6

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$25.4M
2
AGN
Allergan plc
AGN
+$2.3M
3
PFE icon
Pfizer
PFE
+$1.93M
4
ABBV icon
AbbVie
ABBV
+$1.35M
5
DD
Du Pont De Nemours E I
DD
+$1.19M

Sector Composition

Rank Sector Weight
1 Healthcare 70.52%
2 Financials 8.46%
3 Technology 4.11%
4 Real Estate 3.89%
5 Industrials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STWD icon
101
Starwood Property Trust
STWD
$5.85B
$9K ﹤0.01%
400
AMLP icon
102
Alerian MLP ETF
AMLP
$13.4B
$7K ﹤0.01%
120
SCU
103
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$6K ﹤0.01%
200
RMR icon
104
The RMR Group
RMR
$332M
$1K ﹤0.01%
16
MRK icon
105
Merck
MRK
$366B
-1,362
Closed -$83K
HTZ
106
DELISTED
Hertz Global Holdings, Inc.
HTZ
-17,265
Closed -$173K
AGN
107
DELISTED
Allergan plc
AGN
-9,446
Closed -$2.3M
DD
108
DELISTED
Du Pont De Nemours E I
DD
-14,700
Closed -$1.19M

Similar funds

David M. Knott's Q3 2017 Portfolio in Review

As of Q3 2017, David M. Knott held 114 positions worth $234M, down 2.4% from $240M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

David M. Knott withdrew a net $22.7M in Q3 2017, closing 6 positions and reducing 9 holdings. Its most notable exit was Allergan plc, an estimated $2.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, down from 73% a quarter earlier, followed by Financials and Technology.

Against the trend, David M. Knott opened a new position in Atlas Corp. worth $993K.

  • David M. Knott's largest Q3 2017 buy was Atlas Corp.: 140,000 shares worth $993K.
  • David M. Knott added most to DuPont de Nemours in Q3 2017, an estimated $1.24M increase.
  • David M. Knott's biggest Q3 2017 reduction was Ligand Pharmaceuticals, cutting an estimated $25.4M.
  • David M. Knott fully exited Allergan plc in Q3 2017, selling an estimated $2.3M.
  • David M. Knott's ten largest holdings make up 77% of its $234M portfolio in Q3 2017.
  • David M. Knott opened 24 new positions and closed 6 in Q3 2017.
  • David M. Knott's portfolio value fell 2.4% quarter-over-quarter to $234M.

Based on David M. Knott's 13F filing for Q3 2017, filed 13 Nov 2017.